Publicaciones en las que colabora con Javier Arbizu Lostao (26)

2021

  1. Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis

    Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

2015

  1. A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheres: The QUEST Phantom Study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 42, Núm. 8, pp. 1202-1222

  2. Brain PET imaging optimization with time of flight and point spread function modelling

    Physica Medica, Vol. 31, Núm. 8, pp. 948-955

2014

  1. Nuclear Medicine Procedures for Treatment Evaluation and Administration

    Liver Radioembolization with 90Y Microspheres (Springer-Verlag), pp. 63-75

  2. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization

    Medical Physics, Vol. 41, Núm. 9

2013

  1. Aportación del tiempo de vuelo y de la modelización de la respuesta a una fuente puntual a las características de funcionamiento del tomógrafo PET/TAC Biograph mCT

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 32, Núm. 1, pp. 13-21

  2. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 9, pp. 1394-1405

2012

  1. Decreased carbon-11-flumazenil binding in early Alzheimer's disease

    Brain, Vol. 135, Núm. 9, pp. 2817-2825

  2. Quantitative volumetric analysis of gliomas with sequential MRI and 11C-methionine PET assessment: Patterns of integration in therapy planning

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, Núm. 5, pp. 771-781

2011

  1. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation

    Journal of Nuclear Medicine, Vol. 52, Núm. 6, pp. 865-872

2010

  1. Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease

    Stroke, Vol. 41, Núm. 12, pp. 2889-2893

  2. Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient

    Computers in Biology and Medicine, Vol. 40, Núm. 1, pp. 75-80

  3. Neuroimagen: Fundamentos técnicos y prácticos

    Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210

  4. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study

    Neurobiology of Disease, Vol. 38, Núm. 3, pp. 456-463

2009

  1. Cortical atrophy and language network reorganization associated with a novel progranulin mutation

    Cerebral Cortex, Vol. 19, Núm. 8, pp. 1751-1760

  2. New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification

    NeuroImage, Vol. 47, Núm. 2, pp. 533-539

2008

  1. Síntesis rápida y simplificada de 11C-(+)-α- dihidrotetrabenazina para su utilización como radioligando PET de los transportadores vesiculares de monoaminas

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 1, pp. 13-21

  2. Utilización de la11C-(+)-α-dihidrotetrabenazina para la evaluación de la inervación dopaminérgica en modelos animales de la enfermedad de Parkinson

    Revista Espanola de Medicina Nuclear, Vol. 27, Núm. 2, pp. 103-111

2006

  1. Simple automated system for simultaneous production of 11C-labeled tracers by solid supported methylation

    Applied Radiation and Isotopes, Vol. 64, Núm. 7, pp. 808-811